News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
January, 2025
January 2025
M T W T F S S
 12345
6789101112
13141516171819
20212223242526
2728293031  
Secondary analysis of a prospective, phase II RCT for metastatic HNSCC – Memorial Sloan Kettering Radiation Oncology
Photo from Memorial Sloan Kettering Radiation Oncology/X
Jun 7, 2024, 20:40

Secondary analysis of a prospective, phase II RCT for metastatic HNSCC – Memorial Sloan Kettering Radiation Oncology

Memorial Sloan Kettering Radiation Oncology shared on X:

“New from Drs James Janopaul-Naylor and Sean McBride:.

This secondary analysis of a prospective, phase II RCT for metastatic HNSCC (nivolumab +/− SBRT) found no significant impacts on efficacy and toxicity of treatment time-of-day/circadian rhythm.”.

Source: Memorial Sloan Kettering Radiation Oncology/X

cancer HNSCC James Janopaul-Naylor Memorial Sloan Kettering Radiation Oncology OncoDaily Oncology radiation oncology Sean McBride
Special Coverage
Blog
Jan 16, 2025, 22:31
Andrea Necchi: All you need to know about TAR-200
Blog
Jan 16, 2025, 22:27
Jutta Heix: Bridging innovations to improve clinical outcomes for cancer patients
Blog
Jan 16, 2025, 22:26
Vivek Subbiah: Novel Precision Oncology Trial Designs in Early Phase Clinical trials
Blog
Jan 16, 2025, 22:20
Ultrasensitive ctDNA detection for preoperative disease stratification in early-stage lung adenocarcinoma
Blog
Jan 16, 2025, 22:19
Don’t miss the ESMO Sarcoma and Rare Cancers Congress 2025!
Blog
Jan 16, 2025, 22:17
European School of Oncology Clinical Training Centres Fellowship programme
Celebrities
Jan 16, 2025, 17:18
Bob Uecker Dies at 90 from Small-Cell Lung Cancer
Insight
Jan 16, 2025, 16:45
The 2025 CACA-OncoDaily-SPCC Cancer Summit: Bridging Continents
Insight
Jan 16, 2025, 16:28
ACS CAN Report: High Costs Block Critical Follow-Up Tests for Breast Cancer
Blog
Jan 16, 2025, 16:20
Genomic features and clinical outcomes following targeted therapy and secondary cytoreductive surgery in OCCC - ASGO Education
Science
Jan 16, 2025, 16:10
Neoadjuvant therapy in patients with left-sided resectable pancreatic cancer
Blog
Jan 16, 2025, 16:05
David Wakeling: Alice’s Arc’s new research grant to some of the best minds in US paediatric cancer research